Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
ICB International logo — Pioneering breakthrough technology enabling new non-invasive...

ICB International

Pioneering breakthrough technology enabling new non-invasive diagnostics and therapeutics for CNS diseases like neurodegeneration, cancer, and infections.

Founded 2008 Series Unknown Total: $895.00K Biotechnology, Health Care +1

General Information

Company Name ICB International
Founded Year 2008
Industries Biotechnology, Health Care, Health and Wellness
Funding Stage Series Unknown
Social

Get notified when ICB International moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About ICB International

ICB International is a biotechnology and healthcare startup that has been pioneering breakthrough technology in the field of non-invasive diagnostics and therapeutics for CNS diseases. Established in 2008, the company's unique blood-brain barrier permeable technology is at the forefront of addressing challenges associated with central nervous system diseases. Utilizing this platform technology, ICBI is working on developing FDA-approved non-invasive diagnostics and treatments for neurodegenerative, cancer, and infectious diseases. The company secured a $895.00K Venture Round investment on 19 April 2013, showcasing investor interest in their innovative approach. With a focus on cutting-edge solutions in the areas of neurodegeneration, cancer, and infections, ICB International stands as a promising player in the biotech and healthcare industry.

Taxonomy: non-invasive diagnostics, therapeutics, CNS diseases, neurodegeneration, cancer treatment, infectious diseases, blood-brain barrier technology, immunology, biomedicine, FDA approval, central nervous system, platform technology, proprietary technology, California Biosciences International

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• - 19 Apr 2013

ICB International Alternatives & Competitors

ICB International vs
MoonLake Immunotherapeutics (NASDAQ: MLTX)
MoonLake Immunotherapeutics (NASDAQ: MLTX) Switzerland

Creating next-level therapies for inflammatory skin and joint diseases with Nanobody® science

Post Ipo Equity
99 employees
Biotechnology
ICB International vs
ECG-Excellence
ECG-Excellence The Netherlands

We support patients and medical professionals in providing better, earlier, lower costs non-invasive...

Convertible Note
4 employees
Biotechnology, Health Care
ICB International vs
Pulse Medical Technology
Pulse Medical Technology

Innovative technology for diagnosing and treating pan-vascular diseases at its finest

Series C
Health Care, Medical Devices

FAQ About ICB International

Pioneering breakthrough technology enabling new non-invasive diagnostics and therapeutics for CNS diseases like neurodegeneration, cancer, and infections.
ICB International was founded in 2008.
ICB International operates in the following industries: Biotechnology, Health Care, Health and Wellness.
ICB International has completed 1 funding round, raising a total of $895.00K. The latest funding stage is Series Unknown.
Top alternatives and competitors to ICB International include MoonLake Immunotherapeutics (NASDAQ: MLTX), ECG-Excellence, Pulse Medical Technology, PYC Therapeutics (ASX: PYC), Mito BioPharm. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
ICB International and MoonLake Immunotherapeutics (NASDAQ: MLTX) are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors ICB International and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy